Patients with immune thrombocytopenia (ITP) who received a first-in-class investigational drug in addition to standard ...
Even beyond the pendulum lurches between presidencies, many of the perennial debates over education policy, politics, and ...
Approval based on phase II NOBILITY and phase III REGENCY studies showing superiority of Gazyva/Gazyvaro over standard ...
Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes ...
Clinicians and health system leaders met in Portland, Oregon, on October 21, 2025, to discuss the evolving options for ...
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback